Method comparison was performed according to Clinical and Laboratory Standards Institute (CLSI) EP9-A2 guidelines. We selected 100 samples from the routine laboratory workload and analyzed them in duplicate with the three analyzers. The imprecision study was performed according to CLSI EP5-A2 guidelines for both inter-assay and intra-assay variability. Bias was assessed with external quality control material. To establish linearity, CLSI EP6-A protocol was followed. Carry-over: 0.0024%.
Introduction
Diabetes Mellitus (DM) has become a global epidemic whose incidence is increasing and which already affects one in twelve people [1] and reduces the quality of life for many millions of people through its complications (retinopathy, renal, vascular and heart diseases, etc.). As a result, glycated hemoglobin (HbA 1c ) is a fundamental parameter in the clinical laboratory, as it has been determined to be an effective, stable and comfortable alternative to blood glucose for both diagnosis and monitoring DM [2, 3] .
HbA 1c is an ideal parameter for diagnosis and control of DM because there is a direct relationship between average blood glucose levels and HbA 1c concentration [4] . HbA 1c is a derivative of hemoglobin, a minor fraction that is generated as a result of non-enzymatic reaction between the aldehyde group of the open structure of the glucose molecule and the free amino group in the terminal valine of the hemoglobin β chain. This reaction occurs with the formation of an unstable intermediate, a Schiff base known as labile hemoglobin. Then, after an Amadori rearrangement, it is stabilized in its ketoamine form constituting HbA 1c [5] .
HbA 1c can be determined by different techniques [6] , which are based on chemical and structural differences between HbA 1c and other hemoglobin fractions. One of those techniques is ion exchange High Performance Liquid Chromatography (HPLC), which exploits the fact that the ionization point (pI) of HbA 1c is different from other hemoglobin fractions. It uses a cation exchange resin to separate HbA 1c .
Although HbA 1c determination for diagnosing and monitoring DM has some limitations, such as the presence of some possible interferences (hemoglobinopathies, carbamylated and labile hemoglobin) or altered half-life of red blood cells (renal failure, hemolytic anemia, etc.), the advantages are many [7] . In addition, many of the disadvantages have been overcome in the newly developed analyzers and for many of them the most common hemoglobin variants do not pose a problem, nor do the carbamylated hemoglobin [8] or labile hemoglobin [6] .
HPLC techniques are considered the gold standard in the determination of HbA 1c and are among the most widespread in clinical laboratories. In this study we compared the performance of three HPLC analyzers for HbA 1c .
Materials and methods
We studied three HbA 1c analyzers: G8
s from Tosoh Bioscience (Tokyo, Japan) (G8); D-100 s from Bio-Rad Laboratories (Hercules, CA, USA) (D-100); and HA-8180V s from A Menarini Diagnostics (Firenze, Italy) (HA-8180V). These three instruments employ the same measurement principle: ion exchange HPLC, preceded by a pre-filter to avoid the rapid deterioration of the column. The detection system is a photometer, which quantifies the different hemoglobin fractions identified by their specific retention time. The instruments were calibrated according to the manufacturers' specifications and we performed daily internal quality control with two levels of quality control, one high and one low, provided by the manufacturers. . We analyzed the samples in duplicate on all three analyzers with less than 2 h between the first and last samples.
Precision
The precision study was performed according to CLSI EP5-A2 guidelines for both inter-assay and intra-assay variability. The inter-assay variability was determined with a pool of samples, aliquoted and frozen at À 80°C. We measured one aliquot per day for twenty consecutive days.
For intra-assay variability we selected two samples: one with a high HbA 1c value and other with a low HbA 1c value. We measured both samples twenty consecutive times in the same run.
Accuracy
The bias of the method was assessed by analyzing for twenty consecutive days the three levels of Liquicheck s Diabetes
Control from Bio-Rad (Hercules, CA), prepared from whole human blood for external quality control. Using the results obtained from the D-100 and the target value we calculated total and relative bias.
Linearity
To establish the linearity, CLSI EP6-A protocol was followed. We selected two samples with values 4.4% and 13.9% HbA 1c, respectively (both samples had the same hemoglobin concentration, 13.7 g/dL). The samples were mixed according to the proportions 0:4, 1:3, 2:2, 3:1, 4:0, (v/v), and HbA 1c content was determined for each mixture.
Carry-over
Carry-over was assessed following the "Protocols for Determination of Limits of Detection and Limits of Quantitation" (1986) [9] . We used 2 samples: High sample (H) with 14% HbA 1c , and Low sample (L) with 5% HbA 1c . We analyzed them in the following order: L1L2L3H1H2L4H3H4L5L6L7L8H5H6L9H7H8L10H9H10L11 [9] .
Statistical analysis
For the method comparison we used Passing-Bablok non parametric regression and Pearson correlation coefficient (r) was calculated. The confidence intervals (95%) were determined. The bias was estimated using a Bland-Altman plot and a relative difference plot. Coefficients of variation (CV%) were calculated to estimate the intra and inter-assay variability. Data analysis and statistical calculations were performed using Method Validator (Philippe Marquis Software) and SPSS (IBM Analytics, Armonk, NY, USA).
Results

Method comparison
D-100 vs G8
Passing-Bablok non parametric regression analysis showed a slope of 0.973 with a 95% confidence interval (CI) of (0.963-0.983), and an intercept of À 0.07, with CI ( À0.07: À 0.069) (Fig. 1) . The Pearson Correlation Coefficient between both measurement methods was 0.9989.
The Bland-Altman plot (Fig. 2) shows a mean difference of À 0.229%HbA 1c (CI: À 0.256: À 0.202).
Relative bias plot (Fig. 3 ) D-100/G8 vs D100-G8 gives a mean ratio (D-100/G8) of 0.971 (CI: 0.967À 0.975).
D-100 vs HA-8180V
Passing-Bablok regression (Fig. 4) showed a slope of 0.944 (CI: 0.932-0.958), and intercept of 0.078 (CI: À0.024À 0.173); r¼ 0.9989 (Fig. 3) . 
Imprecision and bias
Results for inter-assay and intra-assay variability are shown in Table 1 in both National Glycohemoglobin Standardization Program (NGSP; % HbA 1c ) and International Federation of Clinical Chemistry (IFCC; mmol/mol Hb) units.
Linearity and carry-over
The instrument response in the concentration range between 4.4% and 13.9% HbA 1c (24.6-128.4 mmol/mol Hb) was completely linear, (r 2 ¼0.9935). The percentage of carry-over calculated for the instrument was 0.0024% in NGSP units (%HbA 1c ) and 0.026% in IFCC units (mmol/mol Hb). 
Discussion
The Bio-Rad D-100 shows good correlation with both reference instruments Tosoh G8 and Menarini HA-8180V, with a Pearson correlation coefficient of 0.998, the same for both comparisons. This value agrees with the one published in another similar study, in which the D-100 is compared with another HPLC instrument [10] .
On a more detailed analysis with a Passing-Bablok regression, it was observed that, both using G8 as reference instrument, and in the comparison with HA-8180V, the intercepts for both regression lines did not show statistically significant differences between the methods. The 95% confidence intervals (CI) both included zero. However, the slopes, with confidence intervals (0.963-0.983) and (0.932-0.958), for G8 and HA-8180V respectively, slightly deviate from the ideal slope, showing a small proportional systematic difference that can be quantified at 2.7% against the G8 and 5.6% against the HA-8180V.
This systematic difference appears again in the results in Bland-Altman plots (Figs. 2 and 5 ), which shows a negative bias for high HbA 1c values present in both comparisons, quantified in the mean differences obtained. In the comparison with G8 (Figs. 3 and 6) , there is still an important bias present, but it affects the whole range of HbA 1c concentrations, reaching in the case of D100/G8 plot a similar value to the proportional error obtained for the Passing-Bablok: À2.9% (mean ratio ¼0.971) but higher in D-100/HA-8180V plot: À4.5% (mean ratio ¼0.955).
This problem with bias also appears in the accuracy study. The evaluation of bias using an external quality control (Table 1) proved again the existence of a negative bias in D-100. And, as the results in Bland-Altman plot expressed, the bias is greater for higher HbA 1c concentrations (1.55% for Liquicheck 1 at 5.34%HbA 1c , 1.931% for Liquicheck 2 at 9.5% HbA 1c , and 3.515% for Liquicheck 3 at 14.6%HbA 1c ). This progressive bias might be due to a problem with the calibration protocol or traceability of calibration materials. Nevertheless, it seems to affect mainly higher HbA 1c concentrations, in which case it would not be a critical interference in clinical or diagnostic decisions.
HbA 1c is a longitudinal parameter, used in monitoring diabetes over the patient's lifetime. Therefore, the reproducibility and repeatability of HbA 1c measurements must be well controlled. To assess the variability in the D-100 instrument, we determined intra-assay CV with two samples, one with a low concentration of HbA 1c (4.7%) and one with a high concentration (11.4%), obtaining CV values of 1.05% (%HbA 1c ) [1.97% (mmol/mol)] and 0.78% (%HbA1c) [0.99% (mmol/mol)], respectively. Both CVs are lower than the lowest CV obtained in several studies performed with the D-100 [10] and with other instruments [11] . Also, these CV values meet the recommendations made by Sacks et al. [12] of within-laboratory CV below 2%. The inter-assay CV% estimated was 0.81% (%HbA 1c ) [1.51% (mmol/mol)], an excellent result which meets the criteria required for the determination of HbA 1c [13] , which are higher in IFCC units (mmol/mol) than in NGSP units (% HbA 1c ) [14] .
The linear response of the instrument has been confirmed in the range between 3.4% and 13.9%HbA 1c (24.6-128.4 mmol/ mol), which represents the HbA 1c concentration range involved in diagnostic decisions. In some instruments carry-over can distort the results of samples following a sample with high concentration of the analyte. Carryover for the D-100 was tested using the method described by Peters [10] . The result is a carry-over quantified as 0.0024% (%HbA 1c )/0.026% (mmol/mol Hb), which is very satisfactory and similar to carry-over calculated for other analyzers [15] ensuring that there is no contamination after measuring concentrated samples.
Finally, D-100 provides a number of advantages in daily operation, such as the incorporation of computer and control software on the instrument itself, controlled through an easy-to-use touch screen. Through the screen the operator has access to all system controls and configurations; maintenance procedures, change of reagents, performance of analyses, data collection and inspection of chromatograms. The change of reagents, column and pre-filter is very simple and can be done with the equipment running, it not being necessary to change the column for up to 10,000 determinations. Also an excellent throughput should be noted allowing the achievement of only 45 s per determination, which is better than the throughput of the G8 and HA-8180V. 
